CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis

Emily Lerner(Duke University), Peter E. Fecci(Duke University)
Nature Cancer
August 3, 2023
Cited by 131


Related Papers